Apollo Hospitals Enterprise is currently trading at Rs. 1302.45, up by 18.05 points or 1.41% from its previous closing of Rs. 1284.40 on the BSE.
The scrip opened at Rs. 1292.00 and has touched a high and low of Rs. 1303.25 and Rs. 1291.90 respectively. So far 2,380 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1544.00 on 02-Mar-2016 and a 52 week low of Rs. 1110.75 on 26-Dec-2016.
Last one week high and low of the scrip stood at Rs. 1303.25 and Rs. 1222.30 respectively. The current market cap of the company is Rs. 18,120.36 crore.
The promoters holding in the company stood at 34.35%, while Institutions and Non-Institutions held 46.21% and 19.01% respectively.
Apollo Hospitals Enterprise is planning to raise up to Rs 200 crore through issuance of secured Redeemable Non-Convertible Debentures (NCDs) on private placement basis. In this regard, a meeting of the debenture allotment committee of the board of directors will be held on February 23, 2017.
Apollo Hospitals Enterprise owns and operates chain of multi-specialty hospitals. It offers the services in the area of cardiology, cardiothoracic, orthopedics and joint replacement, spine surgery, oncology, medical and surgical gastroenterology, neurology, neurosurgery, nephrology, urology, cyberknife robotic radio, birmingham hip replacement, cosmetic, bariatric, liver and bone marrow transplants.